Description
Added on the 04/12/2010 09:32:37 - Copyright : France 24 EN
Professor Anil Jain from Michigan State University, who at the end of July with a group of his students successfully unlocked a phone using 3D printed fingerprints, explained the breakthrough technique behind the invention to the press at his laboratory on Tuesday.
By 94 votes in favour and 49 against, Senegalese MPs pass an amnesty law covering acts linked to deadly protests in the last three years, a controversial text aimed at calming the crisis sparked by the presidential election delay. IMAGES
Singapore, Oct 5 (EFE/EPA).- The Singapore parliament has passed a law against foreign interference in the politics of the city-state that has been criticized by human rights activists for allegedly granting arbitrary powers to the government.The law, passed at midnight, will compel Internet providers and social media platforms to provide authorities with information about users, block publications, and remove applications, among other things.Those found in violation of the law could face harsh prison sentences and heavy fines. (Camera: ARCHIVE).ARCHIVE B-ROLL OF SINGAPORE.
Athens, Feb 10 (EFE) .- (Camera: Alberto Borreguero) Thousands of students and teachers took to the streets of several Greek cities again on Wednesday to protest against the law that is being debated in Parliament and that plans to create brigades of police officers at universities and limit the number of admissions.FOOTAGE OF PROTESTS IN ATHENS.
Nîmes (30) : Journal du lundi 15 décembre 2014
A new study reveals a COVID-19 vaccine under development in England safely promotes an immune response against the virus. According to UPI, the vaccine is in Phase 2 of clinical trials with Astra Zeneca, and is particularly effective in elderly recipients who are over age 70. Researchers say the finding of the 'robust' responses in older people in their study is both significant and encouraging. The populations at greatest risk of serious COVID-19 disease include people with existing health conditions and older adults. The so-called "Oxford vaccine," formally known as ChAdOx1 nCoV-19, is one of more than 120 being evaluated in response to the COVID-19 pandemic. To date, 48 of these vaccines have gotten into clinical trials to assess their safety and efficacy.